Objectives Gastroparesis is a common complication of SSc. We sought to determine the
degree of overlap between gastroparesis and dysmotility in other areas of the gut, correlate …

Objective Although up to 90% of systemic sclerosis (SSc) patients are affected by
gastrointestinal (GI) dysmotility, the clinical phenotype of patients with pseudo-obstruction is …

Objective A subset of patients with systemic sclerosis (SS c) develop severe gastrointestinal
(GI) dysmotility. We sought to determine predictors of severe SS c GI dysmotility and to …

Objective Systemic sclerosis (SSc)–associated gastrointestinal (GI) complications are
attributed to a variety of factors, including diet, microbiota dysbiosis, or GI transit …

Background Systemic Sclerosis (SSc) is an autoimmune condition of unknown etiology. We
aim to investigate incidence, characteristics, and risk factors for gastrointestinal (GI) …

Objective The University of California Los Angeles Scleroderma Clinical Trials Consortium
Gastrointestinal Tract 2.0 (GIT 2.0) instrument is a self-report tool measuring gastrointestinal …

Abstract Background. Systemic sclerosis (SSc) is an autoimmune disease characterized by
fibrosis and collagen deposits. Gastrointestinal symptoms of SSc, including abdominal pain …

Objective: Scleroderma (SSc)-associated gastrointestinal (GI) complications are attributed to
a variety of factors including diet, microbiota dysbiosis, or GI transit abnormalities. We …

Systemic sclerosis is an autoimmune disease characterized by vasculopathy, progressive
fibrosis of the skin, and internal organ dysfunction. Gastrointestinal (GI) disease is the most …

Objective The gastrointestinal tract is commonly involved in patients with systemic sclerosis
(SSc) with varied manifestations. As our understanding of SSc gastrointestinal disease …